EVENTS: endTB at Union conference (26-29 October 2016)

October 24, 2016
Medical staff work in the ambulatory ward at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi. Patient Goderdzi Rajabishvili (left) recovers from his morning infusion of imipenem, an antibiotic drug used for the treatment of MDR-TB. (Daro Sulakauri)

Medical staff work in the ambulatory ward at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi. Patient Goderdzi Rajabishvili (left) recovers from his morning infusion of imipenem, an antibiotic drug used for the treatmen

Attending the Union conference in Liverpool this week (26-29 October) ?

Don’t miss these events from endTB and partners:

endTB Symposium

Thursday 27 October  13:30 – 15:00, Session Room 3A

Introducing bedaquiline and delamanid for drug-resistant TB under routine programme conditions: preliminary results from the endTB initiative

Organized by endTB  

Satellite

Thursday 27 October 07:30 – 08:45, Session Room 3B

Pushing the boundaries: use of new TB drugs, the MSF experience

This satellite will share the combined experience of MSF and NTPs from different settings, in opening up the access to new drugs and expanding their indications and use, including the use of delamanid and bedaquiline in combination, delamanid in children and extended use beyond 24 weeks of bedaquiline and delamanid

Organized by MSF  

Symposium

Thursday 27 October 18:00 – 21:00, Jurys Inn, No. 31 Keel Wharf, Suite (close to Conference Centre) No registration required – free to public.

Stop double standards: from prevention through cure to zero TB

Organized by TAG, AA&D, Partners In Health, Harvard Medical School, and the Stop TB Partnership  

PIH MSF MSF UNITAID